Zim Laboratories Limited (ZIMLAB) — Cash Flow-to-Debt Ratio
Zim Laboratories Limited (ZIMLAB) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2023, meaning its operating cash flow of Rs81.71 Million could theoretically repay 0% of its total liabilities (Rs1.40 Billion) in one year. See ZIMLAB financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zim Laboratories Limited Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Zim Laboratories Limited across 13 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Zim Laboratories Limited.
Annual Cash Flow-to-Debt Ratio for Zim Laboratories Limited (2013–2025)
Year-by-year debt coverage analysis for Zim Laboratories Limited. Check ZIMLAB cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | Rs411.55 Million | Rs2.20 Billion | ▲ +139.4% |
| 2024 | 0.08x | Rs162.78 Million | Rs2.08 Billion | ▼ -70.6% |
| 2023 | 0.27x | Rs375.19 Million | Rs1.41 Billion | ▼ -10.4% |
| 2022 | 0.30x | Rs492.06 Million | Rs1.66 Billion | ▲ +52.7% |
| 2021 | 0.19x | Rs318.51 Million | Rs1.64 Billion | ▲ +51.9% |
| 2020 | 0.13x | Rs219.15 Million | Rs1.71 Billion | ▼ -35.0% |
| 2019 | 0.20x | Rs348.65 Million | Rs1.77 Billion | ▼ -13.2% |
| 2018 | 0.23x | Rs366.13 Million | Rs1.62 Billion | ▼ -0.6% |
| 2017 | 0.23x | Rs320.71 Million | Rs1.41 Billion | ▲ +63.9% |
| 2016 | 0.14x | Rs219.43 Million | Rs1.58 Billion | ▲ +325.4% |
| 2015 | 0.03x | Rs55.85 Million | Rs1.71 Billion | ▲ +44.0% |
| 2014 | 0.02x | Rs33.48 Million | Rs1.48 Billion | ▲ +110.9% |
| 2013 | -0.21x | Rs-231.81 Million | Rs1.11 Billion | — |